Envoy Medical, Inc. (COCH) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 2 Buy.
The consensus price target is $6.00, representing an upside of 733.3% from the current price $0.72.
Analysts estimate Earnings Per Share (EPS) of $-1.28 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.49 vs est $-1.28 (missed -16.4%). 2025: actual $-1.23 vs est $-1.19 (missed -3.4%). Analyst accuracy: 91%.
COCH Stock — 12-Month Price Forecast
$6.00
▲ +733.33% Upside
Average Price Target
Based on 2 Wall Street analysts offering 12-month price targets for Envoy Medical, Inc., the price target is $6.00.
The average price target represents a +733.33% change from the last price of $0.72.
COCH Analyst Ratings
Buy
Based on 2 analysts giving stock ratings to Envoy Medical, Inc. in the past 3 months
EPS Estimates — COCH
91%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$1.49
vs Est –$1.28
▼ 14.1% off
2025
Actual –$1.23
vs Est –$1.19
▼ 3.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — COCH
82%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▼ 18.5% off
2025
Actual $0.000B
vs Est $0.000B
▲ 17.0% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
